Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Batzler

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Pharmacogenomics and Personalized Medicine|March 1, 2017
Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6Paul Y Takahashi, Euijung Ryu, Jyotishman Pathak, et al.
Journal of the American Heart Association|July 27, 2019
Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular DiseaseYogesh N V Reddy, Seethalakshmi R Iyer, Christopher G Scott, et al.
Circulation. Heart Failure|August 1, 2023
Myocardial Fibrosis and Cardiomyopathy Risk: A Genetic Link in the MESAMahsima Shabani, Min Wang, Gregory D Jenkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomicsLiewei Wang, Shaji Kumar, Brooke L Fridley, et al.
Physiological Genomics|March 20, 2008
Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine releaseYuan Ji, Eric M Snyder, Brooke L Fridley, et al.
BMC Cancer|September 26, 2012
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association studyNifang Niu, Daniel J Schaid, Ryan P Abo, et al.
Pharmacogenetics and Genomics|December 17, 2011
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancerLiang Li, Daniel J Schaid, Brooke L Fridley, et al.
Journal of the National Cancer Institute|November 7, 2020
Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced AmenorrheaKathryn J Ruddy, Daniel J Schaid, Anthony Batzler, et al.
Bipolar Disorders|February 26, 2025
Exploration of Genetic Liability to Insomnia and Substance Use Disorders in Patients With Bipolar DisorderLindsay M Melhuish Beaupre, Brandon J Coombes, Anthony Batzler, et al.
Pharmacogenetics and Genomics|January 18, 2013
FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorderKatarzyna A Ellsworth, Irene Moon, Bruce W Eckloff, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Pharmacogenomics and Personalized Medicine|March 1, 2017
Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6Paul Y Takahashi, Euijung Ryu, Jyotishman Pathak, et al.
Journal of the American Heart Association|July 27, 2019
Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular DiseaseYogesh N V Reddy, Seethalakshmi R Iyer, Christopher G Scott, et al.
Circulation. Heart Failure|August 1, 2023
Myocardial Fibrosis and Cardiomyopathy Risk: A Genetic Link in the MESAMahsima Shabani, Min Wang, Gregory D Jenkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomicsLiewei Wang, Shaji Kumar, Brooke L Fridley, et al.
Physiological Genomics|March 20, 2008
Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine releaseYuan Ji, Eric M Snyder, Brooke L Fridley, et al.
BMC Cancer|September 26, 2012
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association studyNifang Niu, Daniel J Schaid, Ryan P Abo, et al.
Pharmacogenetics and Genomics|December 17, 2011
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancerLiang Li, Daniel J Schaid, Brooke L Fridley, et al.
Journal of the National Cancer Institute|November 7, 2020
Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced AmenorrheaKathryn J Ruddy, Daniel J Schaid, Anthony Batzler, et al.
Bipolar Disorders|February 26, 2025
Exploration of Genetic Liability to Insomnia and Substance Use Disorders in Patients With Bipolar DisorderLindsay M Melhuish Beaupre, Brandon J Coombes, Anthony Batzler, et al.
Pharmacogenetics and Genomics|January 18, 2013
FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorderKatarzyna A Ellsworth, Irene Moon, Bruce W Eckloff, et al.
Pageof 8